Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
19.18
-0.07 (-0.36%)
At close: Oct 16, 2026, 4:00 PM EDT
19.75
+0.57 (2.95%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $6.68 billion as of October 16, 2026. It is the 2,903rd most valuable company in the world and the 954th biggest in the United States. Its market cap has increased by 117.48% in one year.
Market Cap
6.68B
Enterprise Value
9.34B
1-Year Change
117.48%
Global Rank
Country Rank
#954 United States
Category
ChartMarket Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has increased from $5.76B to $6.68B, an increase of 15.97%. That is a compound annual growth rate of 1.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 6.13B | 54.64% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 13.79B |
| Elanco Animal Health | 11.77B |
| Dr. Reddy's Laboratories | 10.81B |
| Alkermes | 6.92B |
| Hims & Hers Health | 6.55B |
| Lantheus Holdings | 6.51B |
| Kiniksa Pharmaceuticals International, | 6.13B |
| Regencell Bioscience Holdings | 4.76B |